Rockwell Medical, Inc. (RMTI) financial statements (2021 and earlier)

Company profile

Business Address 411 HACKENSACK AVE., SUITE 501
HACKENSACK, NJ 07601
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26142128341823
Cash and cash equivalents121421212342
Short-term investments14  7111321
Receivables4557786
Inventory, net of allowances, customer advances and progress billings4444455
Inventory4444455
Other undisclosed current assets317172222
Total current assets:37414840473236
Noncurrent Assets
Inventory, Noncurrent0112222
Operating lease, right-of-use asset333 
Property, plant and equipment2333333
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Other noncurrent assets0111110
Other undisclosed noncurrent assets   3   
Total noncurrent assets:7899666
TOTAL ASSETS:44485749533841
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8781110107
Accounts payable3345473
Accrued liabilities5446534
Deferred revenue222 
Debt112    
Estimated litigation liability0000012
Due to related parties00011  
Other undisclosed current liabilities1124222
Total current liabilities:12121516131311
Noncurrent Liabilities
Long-term debt and lease obligation222    
Operating lease, liability222 
Liabilities, other than long-term debt101011    
Deferred revenue101011 
Other undisclosed noncurrent liabilities   13121313
Total noncurrent liabilities:12121313121313
Total liabilities:24242729252525
Stockholders' equity
Stockholders' equity attributable to parent, including:20243020271317
Additional paid in capital327323     
Accumulated other comprehensive income (loss)000000(0)
Accumulated deficit(307)(299)(291)(281)(272)(263)(258)
Other undisclosed stockholders' equity attributable to parent00321301300276275
Total stockholders' equity:20243020271317
TOTAL LIABILITIES AND EQUITY:44485749533841

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues15151516171715
Cost of revenue
(Cost of Goods and Services Sold)
(14)(15)(14)(15)(16)(15)(19)
Gross profit:1(0)1112(4)
Operating expenses(9)(8)(11)(10)(10)(7)(8)
Other undisclosed operating loss    (1)  
Operating loss:(7)(8)(10)(9)(9)(5)(12)
Nonoperating income0000000
Investment income, nonoperating     00
Other nonoperating income0000   
Net loss available to common stockholders, diluted:(7)(8)(10)(9)(9)(5)(12)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(7)(8)(10)(9)(9)(5)(12)
Comprehensive loss:(7)(8)(10)(9)(9)(5)(12)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00(0)000
Comprehensive loss, net of tax, attributable to parent:(7)(8)(10)(9)(9)(5)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: